News

Watch as Regis Kowalski, Executive Director, The Charles T. Campbell Laboratory at the University of Pittsburgh, explains how newly discovered resurgent isolates may affect clinical practice.

Ocular surface disease (OSD) is a prevalent, chronic, and progressive condition with an often multifactorial etiology. A comprehensive approach to detection, treatment, and monitoring is required.

As parents and educators around the country are preparing this August for “Back to School” season, it is also Child’s Eye Health and Safety Month, serving as a reminder for parents, educators, and eye-care providers of the importance of vision screening for children. Plus, a new device may help specialists properly diagnose viral or bacteria pink eye in their pediatric patients.

The best candidates for multifocal intraocular lenses (IOLs) are highly motivated, have nearly perfect optics, and have healthy tear film. Otherwise, patients could have issues with contrast sensitivity, glare, and haloes.

Isunakinra, an interleukin-1 signaling inhibitor designed for topical ophthalmic administration, did not meet the primary endpoint in a phase III clinical trial for the treatment of moderate-to-severe allergic conjunctivitis.

Clinicians will soon have another treatment option for their patients with non-severe primary open-angle glaucoma (POAG). A micro invasive glaucoma surgical (MIGS) device (CyPass Micro-Stent, Alcon) has been approved by the FDA for use in patients with mild-moderate PAOG in conjunction with cataract surgery.

We really are at a crossroads in eye healthcare. Wouldn’t a virtual exam be ‘just as good’ as a trip to the eye doctor? To today’s busy consumer, how can we justify leisurely sitting in front of a computer or in a kiosk versus an in-office visit that takes sixty plus minutes and includes that awkward part – dilation?

In a study including 23 eyes with a transscleral micro-lumen aqueous drainage tube after failing maximum tolerated medication, reductions in the mean IOP were observed as well as in the mean number of medications per day.

My position is that murdering people with poison is a terrible thing, even if the victim is an annoying parent, mother-in-law, or department chair. It's morally wrong, plus the penalty would likely be severe (suspension of operating privileges or even being fired-unless, of course, you have tenure). Yet ophthalmologists certainly have the means to go around poisoning folks.